Form D — Sparrow Pharmaceuticals, Inc.
0001786949-25-000002 · filed 2025-07-01
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $121,400,027
- Total sold
- $61,841,225
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Sparrow Pharmaceuticals, Inc.
- CIK
- 1786949
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1050 Southwest 6th Street
PORTLAND, OR 97204 - Phone
- 6174650328
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Jacks · Executive OfficerPortland, OR Find on LinkedIn ↗
-
Niall O'Donnell · DirectorPortland, OR Find on LinkedIn ↗
-
Zach Scheiner · DirectorPortland, OR Find on LinkedIn ↗
-
Peter Thompson · DirectorPortland, OR Find on LinkedIn ↗
-
Klaus Veitinger · DirectorPortland, OR Find on LinkedIn ↗
-
Nanna L?neborg · DirectorPortland, OR Find on LinkedIn ↗
-
Jonathan Root · DirectorPortland, OR Find on LinkedIn ↗
View original on SEC EDGAR.